(NASDAQ: CVAC) Curevac Nv's forecast annual revenue growth rate of -34.88% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 86.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Curevac Nv's revenue in 2025 is $593,615,116.On average, 1 Wall Street analysts forecast CVAC's revenue for 2025 to be $26,814,228,421, with the lowest CVAC revenue forecast at $26,814,228,421, and the highest CVAC revenue forecast at $26,814,228,421. On average, 2 Wall Street analysts forecast CVAC's revenue for 2026 to be $21,348,484,908, with the lowest CVAC revenue forecast at $15,628,311,316, and the highest CVAC revenue forecast at $27,068,658,500.
In 2027, CVAC is forecast to generate $36,916,003,197 in revenue, with the lowest revenue forecast at $19,314,170,072 and the highest revenue forecast at $54,517,836,321.